Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gary S. Stetz II currently holds 299,000 shares of Hepion Pharmaceuticals, Inc. (HEPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary S. Stetz II has been a net buyer of HEPA stock. They have purchased $25.0K and sold $0 worth of shares.
Gary S. Stetz II's most recent insider trade was on Aug 19, 2026, when they sold 299,000 shares at $0.00 per share.
Gary S. Stetz II serves as Executive at Hepion Pharmaceuticals, Inc. (HEPA). They have executed 3 insider transactions totaling $25.0K over their tenure at the company.
Gary S. Stetz II holds the position of Executive at Hepion Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Gary S. Stetz II has shown a buying trading pattern, with $25.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Gary S. Stetz II was on Aug 3, 2026, when they purchased $25.0K worth of HEPA shares. This transaction involved 500,000 shares at $0.05 per share.
Gary S. Stetz II currently owns 299,000 shares of Hepion Pharmaceuticals, Inc. (HEPA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gary S. Stetz II's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gary S. Stetz II has 3 Form 4 filings on record as an insider at Hepion Pharmaceuticals, Inc..
Set alerts for Gary S. Stetz II and 40,000+ other insiders.